The FDA's approval requires Biogen to further study its ALS drug tofersen to further verify its clinical benefits.
in 2021, which indicated that tofersen failed to meet its main goal of slowing disease progression in patients with amyotrophic lateral sclerosis.
ALS, commonly known as Lou Gehrig's disease, is a progressive and fatal neuromuscular disease that causes nerve cells in the brain and spinal cord to break down over time. Those mutations can cause a protein called SOD1 to accumulate to toxic levels, which damages the nervous system and leads to the development of ALS.
Stephanie Fradette, Biogen's head of ALS development, said those SOD1 protein levels are "indirect evidence" that tofersen targets the rare form of ALS.Another protein called neurofilament light, or NfL, is more strongly associated with the disease's severity and progression in patients, she said.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Biogen tops estimates as revenue slides 3% from a year agoBiogen Inc. said Tuesday it had net income of $387.9 million, or $2.67 a share, for the first quarter, up from $303.8 million, or $2.06 a share, in the...
Baca lebih lajut »
Kamala Harris says wrong name for FDA in interview about mifepristoneHarris mistakenly said the Federal Drug Administration approved the abortion pill mifepristone more than two decades ago — but such an agency doesn’t exist.
Baca lebih lajut »
Foghorn Therapeutics stock slides 21% after FDA puts partial clinical hold on cancer drug trialFoghorn Therapeutics Inc.’s stock slid 21% in premarket trade Monday, after the biotech said the Food and Drug Administration has placed a partial hold on a...
Baca lebih lajut »
FDA Okays Latest Artificial Pancreas, the MiniMed 780GThe updated automated insulin delivery system features so-called meal detection technology and 7-day wear for the insulin pump.
Baca lebih lajut »
Fact Check: Has FDA banned old Covid vaccines?Former UFC star Jake Shields claimed the FDA 'f***** up' as it authorized new COVID vaccine dosage.
Baca lebih lajut »
PolitiFact - Why the FDA is recommending the newer, bivalent COVID-19 vaccinesThe FDA announced that it was revoking the original, monovalent COVID-19 vaccines to replace them with newer, bivalent doses. The change is unrelated to safety. The bivalent vaccines protect against multiple variants and require a single dose.
Baca lebih lajut »